tiprankstipranks
Trending News
More News >
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
US Market

Zelira Therapeutics (ZLDAF) Financial Statements

Compare
16 Followers

Zelira Therapeutics Financial Overview

Zelira Therapeutics's market cap is currently $4.22M. The company's EPS TTM is $; its P/E ratio is -1.62; Zelira Therapeutics is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total RevenueAU$ 656.00AU$ 94.95KAU$ 301.12KAU$ 1.54MAU$ 663.32K
Gross ProfitAU$ -802.95KAU$ 10.28KAU$ -3.22MAU$ -5.72MAU$ -39.16K
Operating IncomeAU$ -3.95MAU$ -5.94MAU$ -7.41MAU$ -13.41MAU$ -9.65M
EBITDAAU$ -4.17MAU$ -36.44MAU$ -6.79MAU$ -13.06MAU$ -9.41M
Net IncomeAU$ -3.63MAU$ -36.57MAU$ -5.57MAU$ -11.95MAU$ -8.55M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 5.66KAU$ 586.16KAU$ 146.21KAU$ 2.75MAU$ 4.97M
Total AssetsAU$ 1.30MAU$ 5.18MAU$ 33.89MAU$ 37.70MAU$ 39.37M
Total DebtAU$ 2.14MAU$ 5.95MAU$ 437.90KAU$ 500.91KAU$ 551.08K
Net DebtAU$ 2.14MAU$ 5.36MAU$ 291.70KAU$ -2.25MAU$ -4.42M
Total LiabilitiesAU$ 5.59MAU$ 9.36MAU$ 2.18MAU$ 2.01MAU$ 1.54M
Stockholders' EquityAU$ -4.46MAU$ -4.51MAU$ 31.80MAU$ 35.20MAU$ 37.83M
Cash Flow
Free Cash FlowAU$ -4.91MAU$ -4.39MAU$ -7.25MAU$ -9.43MAU$ -8.62M
Operating Cash FlowAU$ -4.91MAU$ -4.39MAU$ -7.25MAU$ -9.43MAU$ -8.62M
Investing Cash FlowAU$ 1.15MAU$ 919.74KAU$ 2.83MAU$ -207.78KAU$ 1.38M
Financing Cash FlowAU$ 3.19MAU$ 3.92MAU$ 1.77MAU$ 7.10MAU$ 10.53M
Currency in AUD

Zelira Therapeutics Earnings and Revenue History

Zelira Therapeutics Debt to Assets

Zelira Therapeutics Cash Flow

Zelira Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.